Investments & digital assets › F8949.D.X43
F8949.D.X43 · federal · F8949 line D.X43
Delmar Pharma (acquired 2023-07-05, sold 2025-06-23; proceeds 804.22, basis 978.93, adjustment W 174.71)
0
engine v3
not yet verified
How this number was built
R-8949-LOT One line per sale: proceeds minus basis plus adjustment. Broker basis is used as reported unless a supplemental statement for the same lot is matched.
Sources (6) — where the inputs came from
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 14 · field X43_desc · “Lot X43 description”
read as “Delmar Pharma” → Delmar Pharma
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 14 · field X43_acq · “Lot X43 date acquired”
read as “07/05/2023” → 2023-07-05
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 14 · field X43_sold · “Lot X43 date sold”
read as “06/23/2025” → 2025-06-23
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 14 · field X43_proceeds · “Lot X43 proceeds”
read as “804.22” → 804.22
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 14 · field X43_basis · “Lot X43 cost basis”
read as “978.93” → 978.93
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 14 · field X43_wash · “Lot X43 wash sale loss disallowed”
read as “174.71” → 174.71
99%
Flows into
History — nothing is overwritten
v1 · 2026-03-04: 0v2 · 2026-03-19: 0v3 · 2026-06-23: 0
Adjust this number
Evidence & discussion
Record how you verified it